Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Method for incubating the contents of a receptacle
Nuclear reactor building and construction method thereof
Catecholic butanes and use thereof for cancer therapy
Generation, display, and manipulation of measurements in computer graphical designs
Measurement protocol for a medical technology apparatus
Nucleic acid sequences encoding strictosidine synthase proteins
Semiconductor arrangement with a solder resist layer
  Randomly Featured Patents
Weed guard for electric trolling motors
Method for making a rough design on the surface of an object
Specific binding agents for KSHV vIL-6 that neutralize a biological activity
Interactive vehicular communication system, particular between cars and its method of use
Porous spherical glass filtrating beads and method for the manufacturing thereof
Container for hygienic and cosmetic products
Wafer burn-in test circuit for a semiconductor memory device
Sleeve trocar with penetration indicator
Method of imparting nondurable soil release and soil repellency properties to textile materials